Syntrillo Telehealth Stroke Risk Reduction Study
NCT: NCT07124728 · TERMINATED
Brief Summary
A prospective, single-arm, open-label study evaluating the impact of Syntrillo's telehealth program on stroke risk factors, particularly blood pressure, among 68 high-risk patients. The 6-month intervention includes personalized remote care with blood pressure monitoring, wearable tracking, and multidisciplinary telehealth visits.
Frequently Asked Questions
What is Syntrillo Telehealth Stroke Risk Reduction Study?
Syntrillo Telehealth Stroke Risk Reduction Study is a clinical trial registered under NCT07124728. Current status: TERMINATED.
What is the status of NCT07124728?
The current status of NCT07124728 (Syntrillo Telehealth Stroke Risk Reduction Study) is: TERMINATED.
When did Syntrillo Telehealth Stroke Risk Reduction Study start?
Syntrillo Telehealth Stroke Risk Reduction Study started on 2025-07-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.